As of 2025-05-16, the Intrinsic Value of Milestone Pharmaceuticals Inc (MIST) is -3.89 USD. This MIST valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.15 USD, the upside of Milestone Pharmaceuticals Inc is -438.36%.
Based on its market price of 1.15 USD and our intrinsic valuation, Milestone Pharmaceuticals Inc (MIST) is overvalued by 438.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.89 - -3.89 | -3.89 | -438.36% |
| P/E | (3.02) - (10.15) | (6.95) | -704.0% |
| DDM - Stable | (5.31) - (13.39) | (9.35) | -913.0% |
| DDM - Multi | (4.39) - (8.87) | (5.90) | -613.3% |
| Market Cap (mil) | 61.35 |
| Beta | 2.51 |
| Outstanding shares (mil) | 53.35 |
| Enterprise Value (mil) | 89.39 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.75% |
| Cost of Debt | 5.00% |
| WACC | 7.92% |